Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 641-647

  Alalaf, Shahla ^a  

^a HAWLER MEDICAL UNIVERSITY   (Iraq)

Author keywords

Bemiparin; Hibor; Low dose aspirin; Low molecular weight heparin; Recurrent miscarriage

Indexed keywords

ACETYLSALICYLIC ACID; BEMIPARIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; ANTITHROMBOCYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGE; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SAFETY; EMBOLISM; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; INJECTION SITE ECCHYMOSIS; INJECTION SITE REACTION; IRAQ; LIVE BIRTH; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PARITY; PREECLAMPSIA; PREMATURE LABOR; PRENATAL PERIOD; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; TREATMENT OUTCOME; VAGINAL DELIVERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMBRYO DEATH; PREGNANCY; PREGNANCY OUTCOME;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; EMBRYO LOSS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IRAQ; LIVE BIRTH; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863186157     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2055-y     Document Type: Article

References (22)

1. Bricker L, Farquharson G (2000) Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod 17:1345-1350.
2. Carson A, Branch W (2001) Management of recurrent early pregnancy loss, Compendium selected publications. American College of Obstetricians and Gynecologists, Washington, DC, pp 372-383.
3. Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601-611.
4. Clifford K, Rai R, Waston H, Regan L (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 9:1328-1332.
5. Clark A (1999) Critically examining the immunologic causes of recurrent miscarriage. MedGenMed 1(3). Formerly published in Medscape Women's Health eJournal 4(3); 1999. Available at http://www.medscape.com/veiwarticle/405322.
6. Jauniaux E, Farquharson G, Christiansen B, Exalto N (2006) Evidence-based guidelines for the investigation and medical treatment for recurrent miscarriage. Hum Reprod 21(9):2216-2222. Advance Access originally published online on May 17, 2006. Human Reproduction.
7. Gautam A, Swati A (2003) Low molecular weight heparin in immunological recurrent abortion-the incredible cure. J Assist Reprod Genet 20:2.
8. John H (2003) Antiphospholipid syndrome: an overview. Can Med Assoc J 168(13):1675-1682.
9. Abaci A, Bober E, Yesikaya E, Bidec A, Cinaz P, Buyukgebiz A (2010) Prevalence of anticardiolipin antibodies in type 1 diabetes and autoimmune thyroiditis. Pol Arch Med Wew 120(3):71-75.
10. De Wolf F, Carreras O, Moerman P, Vermylen J, Van A, Renaer M (1982) Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 142(7):829-834.
11. Walport J (1989) Pregnancy and antibodies to phospholipids. Ann Rheum Dis 48:795-797.
12. Mehdi A, Uthman I, Khamashta M (2010) Treatment of antiphospholipid antibody Syndrome. Int J Clin Rheumatol 5(2):241-254.
13. Out J, Kooijman D, Bruinse W, Derksen H (1999) Histopathological findings in placentae from patients with intra uterine fetal death and anti-phospholipids antibodies. Eur J Obstet Gynecol Reprod Biol 41:179-186.
14. Dawes J, Bara L, Billaud E,SammaM(1986) Relationship between biological activity and concentration of a low molecular weight heparin (PK 10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis 16(116):122.
15. Dulitzki M, Pauzner R, Langevitz P, Many A, Schiff E (1996) Low molecular weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol 87:380-383.
16. Asherson A, Cervera R, de Groot G et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12(7):530-534.
17. Kutteh H (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol 174:1584-1589.
18. Carla A, Karen A, Christine A, Mark R, Jeff S et al (2009) Low molecular weight heparin and aspirin loss: result from the randomized, controlled HepASA trail. J Rheumatol. doi: 10.3899/jrheum.080763. Published online before print February 4.
19. Triolo G, Ferrante A, Ciccia F, Accardo-Palum A, Perino A et al (2003) Randomize study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48(3):728-731.
20. Royal College of Obstetrician and Gynaecologists (2003) The investigation and treatment of recurrent miscarriage [internet], Guideline No.
21. Mohamed M, Abdou O, Assem M, Mustafa M, Soghier M (2002) Anticardiolipin antibodies in children with insulin dependent diabetes mellitus. Metabolism. 51:1148-1152.
22. Stef K, Mariette G, Joris M, Van P, Barbara H et al (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 362:1586-1596